平安好醫生、京東健康及阿里健康漲7%-10% 國家藥監局明確藥品網絡銷售禁止清單
恆指現報18,574,反覆回吐161點或0.9%,總成交額770億元。此外,科指現報3,8288,反覆回吐0.3%。
國家藥監局明確藥品網絡銷售禁止清單,市場料利好在線醫療板塊。三大相關股今天全面受捧兼為表現最好科指成份股,其中獲匯豐及大和升價兼維持正面評級的藍籌阿里健康(00241.HK)四連漲,午後高見7.32元,為今年1月以來最高,現報7.28元,急漲10%,成交已達1.25億股。
平安好醫生(01833.HK)四連升兼重越牛熊線(21.35元),最高見21.8元,現報21.25元,續升6.9%,成交1,121萬股。京東健康(06618.HK)繼昨天升至72.85元創年內新高遇阻倒跌後,今天高見71.45元,現報70.05元,回升7.1%,成交994萬股。
國家藥監局組織制定了《藥品網絡銷售禁止清單(第一版)》昨天(1日)實施,其中政策法規明確禁止銷售的藥品包括:疫苗、血液製品、麻醉藥品、精神藥品、醫療用毒性藥品、放射性藥品、藥品類易製毒化學品;醫療機構製劑及中藥配方顆粒。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.